Catalyst
Slingshot members are tracking this event:
Shire (SHPG) Announces Phase 2 Data Analyzing Maribavir in Patients with Cytomegalovirus (CMV) Infection Undergoing Hematopoietic Stem Cell Transplant (HSCT) or Solid Organ Transplant
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| SHPG |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Oct 27, 2016
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Cytomegalovirus Infection, Cmv, Hematopoietic Stem Cell Transplant, Hsct, Infectious Disease Week 2016
